1
|
Vu TH, An HR, Nguyen PT, Seo J, Kim CY, Park JI, Son B, Kim H, Lee HU, Kim MI. Large-sized and highly crystalline ceria nanorods with abundant Ce 3+ species achieve efficient intracellular ROS scavenging. NANOSCALE HORIZONS 2025; 10:791-802. [PMID: 39949300 DOI: 10.1039/d4nh00639a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 03/25/2025]
Abstract
Intracellular reactive oxygen species (ROS) are associated with various inflammatory physiological processes and diseases, highlighting the need for their regulation to mitigate the detrimental effects of oxidative stress and to reduce cellular damage and disease progression. Here, we demonstrate cerium oxide (ceria) nanorods synthesized using a sol-gel method followed by heat treatment, called "AHT-CeNRs", as an efficient intracellular ROS scavenger. The synthesized AHT-CeNRs exhibited exceptional superoxide dismutase (SOD) and catalase (CAT)-like activities, both of which are crucial for converting ROS into harmless products. This was attributed to their high crystallinity, large surface area, numerous defects including oxygen vacancies, and abundant Ce3+ species. AHT-CeNRs exhibited higher CAT-like activities than natural CAT and conventional nanozymes, with a more than five-fold lower Km. When tested on HaCaT human keratinocyte cells, AHT-CeNRs primarily localized to the membrane but effectively scavenged intracellular ROS, potentially through their transmembrane catalytic action without disrupting the membrane. This contrasts with conventional antioxidant nanoparticles that act within the cytosol after penetrating the plasma membrane. AHT-CeNRs maintained cell viability by efficiently scavenging ROS, resulting in approximately 4-fold and 2-fold lower levels of inducible nitric oxide synthase (iNOS) and lactate dehydrogenase (LDH) compared to those in ROS-induced inflammation-stimulator lipopolysaccharide (LPS)-treated control groups, respectively. This simple yet effective method for intracellular ROS scavenging using AHT-CeNRs holds great potential for applications in cell and in vivo therapeutics to regulate intracellular ROS levels.
Collapse
Affiliation(s)
- Trung Hieu Vu
- Department of BioNano Technology, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam, Gyeonggi 13120, Republic of Korea.
| | - Ha-Rim An
- Division of Material Analysis and Research, Korea Basic Science Institute, Gwahak-ro, Yuseong-gu, Daejeon 34133, Republic of Korea.
| | - Phuong Thy Nguyen
- Department of BioNano Technology, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam, Gyeonggi 13120, Republic of Korea.
| | - Jiwon Seo
- Division of Material Analysis and Research, Korea Basic Science Institute, Gwahak-ro, Yuseong-gu, Daejeon 34133, Republic of Korea.
| | - Chang Yeon Kim
- Division of Material Analysis and Research, Korea Basic Science Institute, Gwahak-ro, Yuseong-gu, Daejeon 34133, Republic of Korea.
| | - Ji-In Park
- Division of Material Analysis and Research, Korea Basic Science Institute, Gwahak-ro, Yuseong-gu, Daejeon 34133, Republic of Korea.
| | - Byoungchul Son
- Division of Material Analysis and Research, Korea Basic Science Institute, Gwahak-ro, Yuseong-gu, Daejeon 34133, Republic of Korea.
| | - Hyeran Kim
- Division of Material Analysis and Research, Korea Basic Science Institute, Gwahak-ro, Yuseong-gu, Daejeon 34133, Republic of Korea.
| | - Hyun Uk Lee
- Division of Material Analysis and Research, Korea Basic Science Institute, Gwahak-ro, Yuseong-gu, Daejeon 34133, Republic of Korea.
| | - Moon Il Kim
- Department of BioNano Technology, Gachon University, 1342 Seongnamdae-ro, Sujeong-gu, Seongnam, Gyeonggi 13120, Republic of Korea.
| |
Collapse
|
2
|
Yi L, Yu L, Chen S, Huang D, Yang C, Deng H, Hu Y, Wang H, Wen Z, Wang Y, Tu Y. The regulatory mechanisms of cerium oxide nanoparticles in oxidative stress and emerging applications in refractory wound care. Front Pharmacol 2024; 15:1439960. [PMID: 39156103 PMCID: PMC11327095 DOI: 10.3389/fphar.2024.1439960] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2024] [Accepted: 07/16/2024] [Indexed: 08/20/2024] Open
Abstract
Cerium oxide nanoparticles (CeNPs) have emerged as a potent therapeutic agent in the realm of wound healing, attributing their efficacy predominantly to their exceptional antioxidant properties. Mimicking the activity of endogenous antioxidant enzymes, CeNPs alleviate oxidative stress and curtail the generation of inflammatory mediators, thus expediting the wound healing process. Their application spans various disease models, showcasing therapeutic potential in treating inflammatory responses and infections, particularly in oxidative stress-induced chronic wounds such as diabetic ulcers, radiation-induced skin injuries, and psoriasis. Despite the promising advancements in laboratory studies, the clinical translation of CeNPs is challenged by several factors, including biocompatibility, toxicity, effective drug delivery, and the development of multifunctional compounds. Addressing these challenges necessitates advancements in CeNP synthesis and functionalization, novel nano delivery systems, and comprehensive bio effectiveness and safety evaluations. This paper reviews the progress of CeNPs in wound healing, highlighting their mechanisms, applications, challenges, and future perspectives in clinical therapeutics.
Collapse
Affiliation(s)
- Lijun Yi
- Department of General Surgery, Luzhou People’s Hospital, Luzhou, China
| | - Lijian Yu
- Department of General Surgery, Luzhou People’s Hospital, Luzhou, China
| | - Shouying Chen
- School of Nursing, Southwest Medical University, Luzhou, China
- Wound Healing Basic Research and Clinical Application Key Laboratory of Luzhou, Luzhou, China
| | - Delong Huang
- Department of Clinical Medicine, Southwest Medical University, Luzhou, China
| | - Cheng Yang
- Department of Clinical Medicine, Southwest Medical University, Luzhou, China
- School of Basic Medical Science, Southwest Medical University, Luzhou, China
| | - Hairui Deng
- School of Nursing, Southwest Medical University, Luzhou, China
- Wound Healing Basic Research and Clinical Application Key Laboratory of Luzhou, Luzhou, China
| | - Yiheng Hu
- Department of Medical Imaging, Southwest Medical University, Luzhou, China
| | - Hui Wang
- People’s Hospital of Nanjiang, Bazhong, China
| | - Zhongjian Wen
- School of Nursing, Southwest Medical University, Luzhou, China
- Wound Healing Basic Research and Clinical Application Key Laboratory of Luzhou, Luzhou, China
| | - Yiren Wang
- School of Nursing, Southwest Medical University, Luzhou, China
- Wound Healing Basic Research and Clinical Application Key Laboratory of Luzhou, Luzhou, China
| | - Yu Tu
- Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou, China
| |
Collapse
|
3
|
Scafa Udriște A, Burdușel AC, Niculescu AG, Rădulescu M, Grumezescu AM. Metal-Based Nanoparticles for Cardiovascular Diseases. Int J Mol Sci 2024; 25:1001. [PMID: 38256075 PMCID: PMC10815551 DOI: 10.3390/ijms25021001] [Citation(s) in RCA: 10] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2023] [Revised: 01/06/2024] [Accepted: 01/11/2024] [Indexed: 01/24/2024] Open
Abstract
Globally, cardiovascular diseases (CVDs) are the leading cause of death and disability. While there are many therapeutic alternatives available for the management of CVDs, the majority of classic therapeutic strategies were found to be ineffective at stopping or significantly/additionally slowing the progression of these diseases, or they had unfavorable side effects. Numerous metal-based nanoparticles (NPs) have been created to overcome these limitations, demonstrating encouraging possibilities in the treatment of CVDs due to advancements in nanotechnology. Metallic nanomaterials, including gold, silver, and iron, come in various shapes, sizes, and geometries. Metallic NPs are generally smaller and have more specialized physical, chemical, and biological properties. Metal-based NPs may come in various forms, such as nanoshells, nanorods, and nanospheres, and they have been studied the most. Massive potential applications for these metal nanomaterial structures include supporting molecular imaging, serving as drug delivery systems, enhancing radiation-based anticancer therapy, supplying photothermal transforming effects for thermal therapy, and being compounds with bactericidal, fungicidal, and antiviral qualities that may be helpful for cardiovascular diseases. In this context, the present paper aims to review the applications of relevant metal and metal oxide nanoparticles in CVDs, creating an up-to-date framework that aids researchers in developing more efficient treatment strategies.
Collapse
Affiliation(s)
- Alexandru Scafa Udriște
- Department 4 Cardio-Thoracic Pathology, “Carol Davila” University of Medicine and Pharmacy, 050474 Bucharest, Romania
| | - Alexandra Cristina Burdușel
- Department of Science and Engineering of Oxide Materials and Nanomaterials, Politehnica University of Bucharest, 011061 Bucharest, Romania (A.-G.N.)
| | - Adelina-Gabriela Niculescu
- Department of Science and Engineering of Oxide Materials and Nanomaterials, Politehnica University of Bucharest, 011061 Bucharest, Romania (A.-G.N.)
- Research Institute of the University of Bucharest—ICUB, University of Bucharest, 050657 Bucharest, Romania
| | - Marius Rădulescu
- Department of Inorganic Chemistry, Physical Chemistry and Electrochemistry, University Politehnica of Bucharest, 1-7 Polizu St., 011061 Bucharest, Romania
| | - Alexandru Mihai Grumezescu
- Department of Science and Engineering of Oxide Materials and Nanomaterials, Politehnica University of Bucharest, 011061 Bucharest, Romania (A.-G.N.)
- Research Institute of the University of Bucharest—ICUB, University of Bucharest, 050657 Bucharest, Romania
| |
Collapse
|
4
|
Babu B, Stoltz SA, Mittal A, Pawar S, Kolanthai E, Coathup M, Seal S. Inorganic Nanoparticles as Radiosensitizers for Cancer Treatment. NANOMATERIALS (BASEL, SWITZERLAND) 2023; 13:2873. [PMID: 37947718 PMCID: PMC10647410 DOI: 10.3390/nano13212873] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/07/2023] [Revised: 10/25/2023] [Accepted: 10/27/2023] [Indexed: 11/12/2023]
Abstract
Nanotechnology has expanded what can be achieved in our approach to cancer treatment. The ability to produce and engineer functional nanoparticle formulations to elicit higher incidences of tumor cell radiolysis has resulted in substantial improvements in cancer cell eradication while also permitting multi-modal biomedical functionalities. These radiosensitive nanomaterials utilize material characteristics, such as radio-blocking/absorbing high-Z atomic number elements, to mediate localized effects from therapeutic irradiation. These materials thereby allow subsequent scattered or emitted radiation to produce direct (e.g., damage to genetic materials) or indirect (e.g., protein oxidation, reactive oxygen species formation) damage to tumor cells. Using nanomaterials that activate under certain physiologic conditions, such as the tumor microenvironment, can selectively target tumor cells. These characteristics, combined with biological interactions that can target the tumor environment, allow for localized radio-sensitization while mitigating damage to healthy cells. This review explores the various nanomaterial formulations utilized in cancer radiosensitivity research. Emphasis on inorganic nanomaterials showcases the specific material characteristics that enable higher incidences of radiation while ensuring localized cancer targeting based on tumor microenvironment activation. The aim of this review is to guide future research in cancer radiosensitization using nanomaterial formulations and to detail common approaches to its treatment, as well as their relations to commonly implemented radiotherapy techniques.
Collapse
Affiliation(s)
- Balaashwin Babu
- Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida, Orlando, FL 32826, USA; (B.B.); (S.A.S.); (A.M.); (S.P.); (E.K.)
| | - Samantha Archer Stoltz
- Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida, Orlando, FL 32826, USA; (B.B.); (S.A.S.); (A.M.); (S.P.); (E.K.)
- Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA
| | - Agastya Mittal
- Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida, Orlando, FL 32826, USA; (B.B.); (S.A.S.); (A.M.); (S.P.); (E.K.)
- Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA
| | - Shreya Pawar
- Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida, Orlando, FL 32826, USA; (B.B.); (S.A.S.); (A.M.); (S.P.); (E.K.)
- Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA
| | - Elayaraja Kolanthai
- Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida, Orlando, FL 32826, USA; (B.B.); (S.A.S.); (A.M.); (S.P.); (E.K.)
| | - Melanie Coathup
- Biionix Cluster, University of Central Florida, Orlando, FL 32827, USA;
- College of Medicine, University of Central Florida, Orlando, FL 32827, USA
| | - Sudipta Seal
- Advanced Materials Processing and Analysis Center, Department of Materials Science and Engineering, University of Central Florida, Orlando, FL 32826, USA; (B.B.); (S.A.S.); (A.M.); (S.P.); (E.K.)
- Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32827, USA
- College of Medicine, University of Central Florida, Orlando, FL 32827, USA
- Nanoscience Technology Center, University of Central Florida, Orlando, FL, USA
| |
Collapse
|